Ladenburg Thalmann Starts Acadia Pharmaceuticals (ACAD) at Buy
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $29.50 --0%
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 57
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 57
Join SI Premium – FREE
Ladenburg Thalmann initiates coverage on Acadia Pharmaceuticals (NASDAQ: ACAD) with a Buy.
For an analyst ratings summary and ratings history on Acadia Pharmaceuticals click here. For more ratings news on Acadia Pharmaceuticals click here.
Shares of Acadia Pharmaceuticals closed at $1.51 yesterday.
For an analyst ratings summary and ratings history on Acadia Pharmaceuticals click here. For more ratings news on Acadia Pharmaceuticals click here.
Shares of Acadia Pharmaceuticals closed at $1.51 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU approves Acadia's trofinetide for Rett syndrome treatment
- Nomura/Instinet Starts Sinocera Functional Material (300285:CH) at Neutral
- H.C. Wainwright Starts Inhibrx Biosciences (INBX) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
